Search
for

    Sort by

    Research 121–150 of 1000+

    1. Clinical Case Notes. Malignant melanoma in eviscerated eyeball Clinical and Experimental Ophthalmology · 2004 · 7 citations
    2. Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male) Psychiatric Clinics of North America · 2016 · 26 citations
    3. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials 2022 · 25 citations
    4. 44391 ICI Therapy Toxicities in Psoriasis Journal of the American Academy of Dermatology · 2023
    5. Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study Journal of Community Medicine & Public Health · 2024 · 1 citations
    6. Diphenyl cresyl phosphate [MAK Value Documentations, 2003] 2016
    7. Pharmacokinetics of two different formulations of finasteride (topical and oral) in male volunteers with androgeneic alopecia 2013
    8. Toxicity assessment of the green Dunaliella salina microalgae Toxicology Reports · 2019 · 20 citations
    9. Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome Medicine · 2016 · 15 citations
    10. CLINICAL AND LABORATORY STUDIES ON EMACIATION AND ILL-THRIFTINESS IN CATTLE AT ASWAN GOVERNORATE 2014 · 1 citations
    11. Biologics in the management of childhood atopic dermatitis 2023 · 4 citations
    12. The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial Cancers · 2022 · 8 citations
    13. Promising anitidiabetic potential of Cuscuta reflexa leaves methanol extract in alloxan-induced diabetic rats Clinical Phytoscience · 2020 · 5 citations
    14. Types of Human Stem Cells and Their Therapeutic Applications Stem Cell Discovery · 2014 · 4 citations
    15. Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions 2023 · 1 citations
    16. Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata Mendeley Data · 2025
    17. The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations Healthcare · 2025
    18. Clinical and immunological manifestations in 151 SLE patients living in Dubai Lupus · 2007 · 63 citations
    19. Alcoholic Extract of <i>Eclipta alba</i> Shows <i>In Vitro</i> Antioxidant and Anticancer Activity without Exhibiting Toxicological Effects Oxidative Medicine and Cellular Longevity · 2017 · 49 citations
    20. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Frontiers in Medicine · 2020 · 36 citations
    21. Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata Indian Journal of Dermatology · 2019 · 10 citations
    22. Medical Dermatology Australasian Journal of Dermatology · 2024 · 2 citations
    23. Cutaneous manifestations in patients attending the hematology clinic at King Fahd Hospital of the University during a 13 week-period Nasza Dermatologia Online · 2015 · 1 citations
    24. Desarrollo de una nueva terapia para el tratamiento de lesiones ulcerosas crónicas mediante el trasplante alogénico de una subpoblación de células madre mesenquimales derivadas de cordones umbilicales humanos 2026
    25. A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes Journal of Clinical Medicine · 2025
    26. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
    27. EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management Oncology and therapy · 2017 · 29 citations
    28. Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression BMC chemistry · 2023 · 1 citations
    29. Dodatek A: Model matematyczny AL/RC/ASE. Functional Androgen Axis (FOA) - wersja operacyjna v1.2 Zenodo (CERN European Organization for Nuclear Research) · 2026
    30. Dodatek A: Model matematyczny AL/RC/ASE. Functional Androgen Axis (FOA) - wersja operacyjna v1.2 Zenodo (CERN European Organization for Nuclear Research) · 2026